Nebraska Hematology-Oncology — Lincoln, Nebraska

Nebraska Hematology-Oncology is a clinical research site located in Lincoln, Nebraska, United States 68506.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Nebraska Hematology-Oncology has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Hormone Receptor Positive Tumor, Early-Stage Breast Carcinoma.

Sponsors: Eli Lilly and Company, Loxo Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Hematology-Oncology?

Nebraska Hematology-Oncology has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Hematology-Oncology conducted?

Nebraska Hematology-Oncology has 3 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Hormone Receptor Positive Tumor, Early-Stage Breast Carcinoma.

Is Nebraska Hematology-Oncology accredited by Crixeo Health?

Nebraska Hematology-Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Hematology-Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.